Effect of low-dose Naltrexone versus placebo in the treatment of chronic plaque psoriasis
Phase 2
Recruiting
- Conditions
- Psoriasis.Psoriasis
- Registration Number
- IRCT20120215009014N301
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 154
Inclusion Criteria
Age of 18 to 65 years,
Chronic plaque psoriasis
Exclusion Criteria
Pregnancy or breastfeeding,
Addiction to opium,
Renal or liver failure,
History of convulsion,
Severe mental disorder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method